FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Alaunos Therapeutics, Inc.: operating_income

One fact, its scope and the complete path back to the official record.

Period: 2018-01-01 – 2018-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/8f07a9aa-05dd-47fa-8e70-aae31e98234b

Reported value

$-53.906M{"amount": -53906000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Entity
Alaunos Therapeutics, Inc.
Metric
operating_income
Period
2018-01-01 – 2018-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-19-063978 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T11:06:17.916690+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001107421/operating-income/2018-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.